EMEA-001644-PIP02-14-M03
Table of contents
Key facts
| Invented name |
Axumin
|
| Active substance |
Fluciclovine (18F)
|
| Therapeutic area |
|
| Decision number |
P/0335/2022
|
| PIP number |
EMEA-001644-PIP02-14-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Diagnosis of amino acid metabolism in solid malignant tumours
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Blue Earth Diagnostics Ireland Ltd
E-mail: contact@blueearthdx.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|